Reporting adverse events

Adverse events are defined as any clinical or physical change or disease experienced at any time during a treatment course, and are not necessarily related to the use of the drug(s) being researched.
View further information on Serious Adverse Events

The BSRBR team in Manchester also request that you record Events of Special Interest.

Please report all occurrences of adverse events on BSRBR-registered patients to BSRBR’s offices at the Arthritis Research UK Epidemiology Unit in Manchester.

Please provide all available data for each adverse event to assist BSRBR's pharmacovigilance effort. This information is vital in assessing the safety of these treatments both in the short term and over the life of the register.

If you notify the MHRA of a suspected adverse drug reaction, or a suspected defect in a product through the yellow card scheme, please also send this information to BSRBR.

In addition you may notify or seek advice from the relevant company in relation to the safety of each product:

Abbott – Adalimumab Chiara Dell’aria Burani BSc, MSc Affiliate Safety Representative Pharmacovigilance UK, Ireland & Malta	Abbott UK, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE – UK	PcV: +44 (0)800 121 8267 Tel: +44 (0)16 2864 4175 Fax: +44 (0)16 2864 4236 Email: chaira.dellaria@abbott.com
Biovitrum – Anakinra Gema Retama Senior Pharmacovigilance Specialist	Biovitrum Quintiles Drug Safety and Medical Affairs, Europe Quintiles Ireland Limited East Point Business Park Fairview Dublin 3	Tel: 00 353 1819 5242 Fax: 00 353 1809 9501 Email: gema.retama@quintiles.com
Roche – Rituximab Dr Boshishi Mohlala Drug Surveillance Physician	Drug Safety and Risk Management Roche Products Limited 6 Falcon Way, Shire Park Welwyn Garden City AL7 1TW – UK	Tel: +44 (0)17 0736 7554 Fax: +44 (0)17 0738 4504 Email: boshishi.mohlala@roche.com
Schering Plough – Infliximab Tony Anderson Pharmacovigilance Manager	Schering Plough Ltd Shire Park Welwyn Garden City Hertfordshire AL7 1TW – UK	Tel: +44 (0)17 0736 3989 Fax: +44 (0)17 0736 3690 Mob: +44 (0)78 7674 0029 Email: anthony.anderson@merck.com
Pfizer – Etanercept Nalini Bucktowar Pharmacovigilance Integration Manager	Pfizer Inc Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH – UK	Tel: +44 (0)8453670115 Fax: +44 (0)845 367 0600 Dir: +44 (0)16 2841 4975 Email: nalini.bucktowar@pfizer.com PV mailbox: watwadr@pfizer.com